UPDATE: Evercore ISI Starts Dicerna Pharmaceuticals (DRNA) at Outperform; Alnylam Case Appears Favorable
(Updated - January 16, 2018 5:57 AM EST)
(updated to add analyst comments)Evercore ISI initiates coverage on Dicerna Pharmaceuticals ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(updated to add analyst comments)Evercore ISI initiates coverage on Dicerna Pharmaceuticals ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)